Holen Sie sich die Stockscreener-App
2.4228
1.88%
0.0328
Schlusskurs vom Vortag:
$2.39
Offen:
$2.44
24-Stunden-Volumen:
80,247
Relative Volume:
0.21
Marktkapitalisierung:
$122.14M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.21%
1M Leistung:
-2.60%
6M Leistung:
-42.30%
1J Leistung:
+0.00%
1-Tages-Spanne:
$2.37
$2.4499
1-Wochen-Bereich:
$2.37
$2.65
52-Wochen-Spanne:
$1.80
$7.20
Tuhura Biosciences Inc Stock (HURA) Company Profile
Firmenname
Tuhura Biosciences Inc
Sektor
Branche
Telefon
813-875-6600
Adresse
10500 UNIVERSITY CENTER DR., TAMPA
Vergleichen Sie HURA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HURA
Tuhura Biosciences Inc
|
2.435 | 122.14M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.07 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.04 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
551.61 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
809.47 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.09 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Tuhura Biosciences Inc Stock (HURA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-19 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-11-05 | Eingeleitet | Maxim Group | Buy |
Tuhura Biosciences Inc Aktie (HURA) Neueste Nachrichten
News impact scoring models applied to TuHURA Biosciences Inc.2025 Key Lessons & Step-by-Step Trade Execution Guides - newser.com
Is TuHURA Biosciences Inc. stock gaining market share2025 Market WrapUp & Free Real-Time Market Sentiment Alerts - newser.com
What data driven models say about TuHURA Biosciences Inc.’s future2025 Technical Patterns & Entry and Exit Point Strategies - newser.com
Is TuHURA Biosciences Inc. stock affected by interest rate hikesRate Hike & Growth Oriented Trading Recommendations - newser.com
Analyzing recovery setups for TuHURA Biosciences Inc. investorsStop Loss & Precise Swing Trade Alerts - newser.com
Can a trend reversal in TuHURA Biosciences Inc. lead to recoveryPortfolio Risk Summary & Risk Controlled Daily Trade Plans - newser.com
Can TuHURA Biosciences Inc. (PL3) stock retain market dominanceTrade Volume Report & Low Risk High Reward Ideas - newser.com
Momentum divergence signals in TuHURA Biosciences Inc. chartQuarterly Portfolio Review & Low Risk High Win Rate Picks - newser.com
Can TuHURA Biosciences Inc. hit a new high this monthWeekly Profit Summary & Weekly High Conviction Trade Ideas - newser.com
Using data filters to optimize entry into TuHURA Biosciences Inc.Gold Moves & AI Forecast Swing Trade Picks - newser.com
TuHURA Biosciences' (HURA) "Sell (E+)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Will TuHURA Biosciences Inc. (PL3) stock hit analyst forecastsTrade Signal Summary & Safe Capital Investment Plans - newser.com
Best data tools to analyze TuHURA Biosciences Inc. stockJuly 2025 Spike Watch & Long-Term Investment Growth Plans - newser.com
Combining price and volume data for TuHURA Biosciences Inc.Earnings Growth Report & Precise Swing Trade Entry Alerts - newser.com
Will TuHURA Biosciences Inc. (PL3) stock draw ESG focused funds2025 Earnings Surprises & Real-Time Volume Trigger Notifications - newser.com
Will TuHURA Biosciences Inc. benefit from macro trendsWeekly Gains Summary & Fast Exit and Entry Trade Guides - newser.com
What high frequency data says about TuHURA Biosciences Inc.2025 Year in Review & Reliable Entry Point Trade Alerts - newser.com
Can TuHURA Biosciences Inc. rally from current levelsTrade Risk Summary & Reliable Entry Point Trade Alerts - newser.com
TuHURA Biosciences, Inc. (NASDAQ:HURA) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
TuHURA Biosciences, Inc. (NASDAQ:HURA) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Finanzdaten der Tuhura Biosciences Inc-Aktie (HURA)
Es liegen keine Finanzdaten für Tuhura Biosciences Inc (HURA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):